A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies

Darren C. Phillips, Sha Jin, Gareth P. Gregory, Qi Zhang, John Xue, Xiaoxian Zhao, Jun Chen, Yunsong Tong, Haichao Zhang, Morey Smith, Stephen K. Tahir, Rick F. Clark, Thomas D. Penning, Jennifer R. Devlin, Jake Shortt, Eric D. Hsi, Daniel H. Albert, Marina Konopleva, Ricky W. Johnstone, Joel D. LeversonAndrew J. Souers

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences